1. Bondini S., Younossi Z.M. Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterology Dietol., 2006.-Vol. 52.-№2.-P.135-143. 2. Bugianesi E., Marchesini G., Gentilcore E. et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis.-Hepatology, 2006.- Vol.44.- №6- P.648-655. 3. Bjonrnsson E, Angulo P. Hepatitis C and steatosis. Arch. Med Res, 2007.- Vol.38.-№6.- 621-627. 4. EASL Clinical Practice Guidelines 2016. 5. Eugene J., Yoon and Ke-Qin Hu Hepatitis C virus (HCV) Infection and Hepatic Steatosis. IntJ.Med Sci., 2006.- Vol.3- №2.- P.53-56. 6. Kim K.H., Hong S.P., Kim K., Park M.J. et al. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. BiochemBiophys Res Commun, 2007.- Vol.20.- №355.- P.883-888. 7. Moriishi K., Mochizuki R., Moriya K., et al. Critical role of PA28gamma in hepatitis C, virus – associated steatogenesis and hepatocarcinogenesis. – AcadSci USA, 2007.- Vol. 30.- №5.- P. 1661-1666. 8. Negro F. Mechanisms and significance of liver steatosis in hepatitis C, virus infection. – World Journal Gastroenterology, 2006.- Vol.14 - №42.- P. 6756- 6761. 9. Walsh M.J., Jonsson J.R., Richardson M.M., et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signaling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.- Gut., 2006.- Vol 55.- №4.- P. 529-535. 10. Waris G., Felmlee D.J., Negro F., Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. Journal Virology, 2007.- Vol. 81.- №15.- P.8122-8130. 11. Szanto P., Grigorescu M., Dumitru I., Serban A. Steatosis hepatitis C, virus infection. Response to anti-viral therapy.- Journal Gastrointestin Liver Dis., 2006.- Vol.15.- №2.- P. 117-124.